Sangamo Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Thanks again for tuning in to the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. And our next presenting company is Sangamo Therapeutics. With us to talk to a little -- talk to us a little bit about the company is CEO, Sandy Macrae. (Operator Instructions) With that, Sandy, thanks again for joining us this afternoon.
Thank you, Eric. And I'm going to put the presentation up. And I'm going to ask you all to follow along, and I'll try and remember to say the numbers of the slide to help you do it.
So thank you for joining us for the Sangamo presentation. If there's 3 things I want you to take away from this presentation, it's how much Sangamo has achieved in 2020, our focus on delivery in '21, and the promise of this remarkable company. On the next slide, you can see our forward-looking statements, which, as always, I'd ask you to make sure to refer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |